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AH and 39 (23%) had masked AH. Two-hundred eighteen subjects (86%)
were treated with continuous positive airway pressure. Masked AH was not
associated with the severity of OSAS (AHI and the percentage of total sleep
time during which the oxygen saturation was <90% (SaO2<90%). However,
subjects with masked arterial hypertension have a worst metabolic risk profile
compared to normotensive patients.
Conclusions. Masked hypertension is frequent in OSAS patients and is not
associated with the severity of the OSAS.
Table – Results 
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Peripheral arterial disease remains underdiagnosed even in post hos-
pital discharge for any ischemic event
Patrick Laroche [Orateur] (1), Uwe Diegel (2)
(1) STACTIS, Paris, France – (2) GenNov, Paris, France
Objective: To evaluate the prevalence rates of peripheral arterial disease
(PAD) diagnosed before and during the general practitioner (GP) consultation
following hospitalization for ischemic event.
Method: In a cross sectional study, 102 Belgian GPs recruited 505 patients
of 50 years, hospitalized within the last year for any ischemic event. The
Screening CardioVascular Lab (SCVL®, GenNov) automated combination of
the oscillometric determination of the ankle-brachial index (ABI) and of the
outcome of the Edinburgh questionnaire (EQ). This device integrated the case
report form.
Results: The patients were 69±11 years old; men were 63%. Their other
CV risk factors were: hypertension in 75%; dyslipidemia in 74%; sedentarily
in 53%; abdominal obesity in 52%; familial history of CVD in 38%; smoking
in 28%; diabetes in 22%. The arterial events, which induced the recent hospi-
talizations, were: acute in 71% of cases, planned for revascularization in 23%;
coronary in 50%, cerebral in 29%, aortic/peripheral in 15%. For at least their
hospitalization, 95% of patients were treated with antithrombotics, including
88% with antiplatelets. At the GP visit, PAD was unknown in 10% of cases
and previously diagnosed in 19%, including an appraisal exclusively on clin-
ical signs in 5% and a confirmation by Doppler ultrasonography or arteriog-
raphy in 13%. The EQ had a positive outcome in 16% of patients: the site of
claudication was typical in 85% of these; its severity, of grade 2 in 52%. The
patient ABI was of 0.95±0.20, <0.90 in 37% of patients and >1.30, in 3%. The
combination EQ~ABI was abnormal in 46%. 
Conclusion: In patients recently hospitalized for any ischemic event, the
“true” prevalence rate of PAD, as diagnosed prior to the GP visit, was 19%.
The “apparent” one, by using the SCVL® combining the ABI determination
and the Edinburgh questionnaire at the GP office, was 46%, despite the exten-
sive antithrombotic treatment. Even in a hospital setting, PAD is widely
underdiagnosed.
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Background: Obstructive sleep apnea syndrome (OSAS) is associated
with an increased risk of arterial hypertension (AH) and cardiovascular com-
plications. The aim of this study was to evaluate whether the AH profile,
already known or newly diagnosed, was associated with the severity of the
OSAS.
Methods: Clinical blood pressure and twenty-four-hour ambulatory blood
pressure monitoring were systematically recorded in 253 consecutive patients
with documented OSAS.
Results. In this cohort (mean age 51.3±9.5 years, 83% men, mean BMI
31.8±5.8 kg/m², mean Apnea-Hypopnea Index (AHI) 52.9±28.5%), 82 (32%)
had known AH, 91(36%) had newly diagnosed AH and 80 (32%) had no AH
including white coat effect (25 [15%]). Two hundred and nineteen patients
(86%) were treated with continuous positive airway pressure with no differ-
ence with regard to the AH profile (p=0.305 for trend). The AHI was higher
in OSAS hypertensive patients compared to patients without AH (Table) asso-
ciated with an increased rate of the metabolic syndrome and worst insulin
resistance profile.
Conclusions: We found a continuous relation between the severity of
OSAS, the presence of AH whether already known or newly diagnosed and
the metabolic profile in a large cohort of patients with treated OSAS.
Table – Results
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Objective: To evaluate the efficiency of adrenal imaging by an abdominal
CT scan as first line investigation in subjects with resistant hypertension when
Masked AH
n=39
No AH
n=80
p
Apnea-Hypopnea Index 48.9±23.8 47.7±24.4 0.810
SaO2 <90%,% 12.0±15.3 14.0±17.7 0.579
Age, years 49.6±6.8 49.6±9.4 0.995
Body mass index, kg/m² 30.1±5.5 30.0±5.4 0.947
Fasting glycemia, mg/dL 94±13 94±34 0.148
Homeostasis model assessment-
estimated insulin resistance 
(HOMA-IR)
3.9±2.9 2.5±2.8 0.031
Fasting triglyceridemia, mg/dL 170±110 130±90 0.004
CRP us, mg/L 4.9±6.6 3.8±2.5 0.980
Metabolic syndrome, n (%)
NCEP ATP III definition
13 (33) 10 (13) 0.007
Known 
AH
n=82
Newly 
diagnosed 
AH
n= 91
No AH
n=80
p
Apnea-Hypopnea Index 56.8±33.5 53.4±25.9 47.7±24.4 0.015
SaO2 <90%,% 19.0±22.0 18.0±20.0 14.0±17.7 0.158
Age, years 55.1±7.9 50.0±8.6 49.6±9.4 0.307
Body mass index, kg/m² 33.9±6.2 31.4±5.3 30.0±5.4 0.299
Fasting glycemia, mg/dL 106±29 97±16 94±34 <0.001
Homeostasis model 
assessment-estimated insulin 
resistance (HOMA-IR)
4.3±3.30 3.7±3.1 2.6 ±2.5 0.06
Fasting tryglyceridemia, 
mg/dL
170±150 158±94 130±90 <0.001
CRP us, mg/L 3.8±2.5 4.1±4.7 3.85±3.7 0.54
Metabolic syndrome, n (%)
NCEP ATP III definition
60 (73.2) 45 (50) 10 (12.5) <0.001
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an adrenal cause is suspected although hormonal tests are recommended as
first line.
Methods: On 134 hypertensive patients uncontrolled by at least a combi-
nation therapy and with a suspicion of secondary hypertension due to adrenal
cause, an abdominal CT scan was performed in first intention. In all subjects,
an exploration of the renin-aldosteron axis in standardized conditions, a 24-
hour urinary cortisol and a WHO recommended biological analysis were also
performed afterwards.
Results: An abnormal morphology of adrenal was detected in 57.5% of
patients. Observed abnormalities were: bilateral hyperplasia (30.6%), unilat-
eral adenoma (15.7%), unilateral hyperplasia (6.7%) and bilateral adenoma
(4.5%). Abnormal adrenal hormonal tests were recorded in 16.4% of patients,
with a primary aldosteronism (A/R corrected> 23) found in 10.4% and
increased urinary cortisol in 6%. Treatment implementation was decided upon
morphologic and hormonal results. At 6 months of follow-up, a controlled
blood pressure was observed in 73.1% of subjects, spironolactone had been
prescribed in 41.8% of subjects and adrenal surgery performed in 3.7% of
patients. If hormonal tests had only been performed, a retrospective analysis
showed that treatment with spironolactone would have been prescribed only in
12.6% of subjects and an adrenal surgery been proposed only in 2.9% of
patients.
Conclusion: In our population of patients with a resistant hypertension and
adrenal disease suspicion, abdominal CT scan as a first line investigation leads
directly to the conclusion of an adrenal aetiology in 45.5% of patients. In con-
trast, a specific treatment would have been undertaken only in 15.5% of
patients if screened by hormonal examinations only. This study suggests that
in subjects with uncontrolled hypertension and suspected to have an adrenal
cause, abdominal CT scan is an efficient first line investigation.
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Do vascular markers predict cardiovascular death in primary prevention?
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Purpose: The purpose of the study was to determine the prognostic signif-
icance of vascular markers in apparently healthy subjects.
Methods: Analyses were based on the Third South-Western French
MONICA Survey (1995-1996) carried out in participants aged 35-64. Vital
status, date and cause of death were obtained 14 years after inclusion. Subjects
with a personal history of Atherosclerotic Cardiovascular Disease or with a
personal history of Severe Chronic Disease were excluded. Pulse Wave
Velocity (PWV), Pulse Pressure (PP), presence of carotid or femoral athero-
sclerotic plaques, and carotid Intima-Media Thickness (IMT) were assessed.
Identification of the determinants of cardiovascular mortality was based on a
multivariable survival analysis.
Results: There were 1144 participants (587 (51%) men). Over the 14-year
study period, there were 63 deaths, 21% due to a cardiovascular cause (Isch-
emic Heart Disease, Atherosclerotic Cerebrovascular Disease or Atheroscle-
rosis). The median 10-year risk of coronary event according to the
Framingham Risk Score (FRS) was 6.4%. PWV, PP, and carotid or femoral
atherosclerotic plaques were all significant and independent determinants of
cardiovascular mortality, whereas carotid IMT was no longer associated with
cardiovascular mortality after adjustment for FRS. The addition of PWV, PP
or atherosclerotic plaques to FRS in a prediction model resulted in an
improvement of the discriminatory value of the model as shown by the C-sta-
tistic which was 0.76 [95% CI: 0.61-0.90] for FRS alone, 0.80 [95% CI: 0.64-
0.95] for FRS and PWV, 0.80 [95% CI: 0.65-0.95] for FRS and PP, and 0.77
[95% CI: 0.60-0.94] for FRS and plaques. Using PWV, PP and plaques in the
prediction model led to a Net Reclassification Improvement of 22, 19 and
25%, respectively.
Conclusion: Vascular markers are independent determinants of cardiovas-
cular mortality risk in apparently healthy subjects in primary cardiovascular
prevention and improve classification of subjects.
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Purpose: Our objective was to assess the long term prognosis value of
ABI in a contemporary large cohort of pts with known CAD.
Methods. Among 834 consecutive male pts hospitalized in 2001-2004 for
coronary artery disease, ABI was measured in 776 pts. ABI –0.9 was consid-
ered as abnormal. ABI –0.9 and > 0.6 was considered as low and ABI0.6 as
very low. The median follow-up was 7.17 years. Total mortality was predicted
with a Cox proportional hazard model.
Results: Mean age (SD) was 60.2 (8.1), 144 pts (18.4%) were diabetic,
155 pts (19.8%) were smokers, and median heart rate was 61 bpm [Interqua-
tile range (IQR)] [57-70]. Mean left ventricular ejection fraction was 0.53
(0.13). 88.5% were on antiplatelet therapy, 75.2% on beta-blocker, 66% on
statin therapy and 54.8% on ACE inhibitors or ARB.
The sample comprised 518 pts (67%) with normal ABI and 258 (33%)
with abnormal ABI (215 (83.3%) pts had a low and 43 (16.7%) a very low
ABI). The cumulative seven-year total mortality rate was 17.6%. In the
normal ABI group, mortality rate was 13.9%, whereas it was 21.4% in the low
and 44.2% in the very low ABI group (p<0.001).
After multivariate adjustment for age, diabetes, tobacco consumption (none;
40 pack-years; >40 pack-years), heart rate, duration of CAD, left ventricular
ejection fraction (>0.5; 0.5 and > 0.35; 0.35), history of chronic obstructive
pulmonary disease or stroke, statin therapy and coronary revascularization,
hazard ratio (HR) for all-cause death was 1.36 (95% CI [0.92; 2.03] p=0.12) for
low ABI and 2.48 (95% CI [1.41; 4.36] p=0.002) for very low ABI compared
to pts with normal ABI. Including ABI in the prediction model significantly
increased the C-statistic (from 0.80 to 0.82, p=0.03).
Conclusion: ABI is a strong and independent long term predictor factor of
all-cause death in CAD. To better identify pts at very high risk, systematic
ABI assessment should be promoted.
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Background: Angina with angiographically normal coronary arteries
(NCA) still has controversial pathophysiological mechanisms. Experimental
studies have shown that coronary blood flow varies with aortic (Ao) stiffness,
but clinical data are poor.
Objective: To assess Ao vascular function by different echocardiographic
techniques in patients (pts) with angina and NCA vs asymptomatic pts.
Methods: Study group consisted of 15 pts with angina and NCA (mean
age 60,9±5,3 yrs) and 15 age and gender- matched control subjects (normal
and hypertensives pts) .
Ascending Ao diameters – derived stiffness indices were: Ao strain, Ao
distensibility (Ao dis), Ao stiffness index (Ao SI). Ao function was evaluated
also by measuring tissue Doppler (TdI) systolic (SW), early and late dia-
stolic(EW, AW) velocities of the anterior Ao wall. Total afterload was defined
by the effective arterial elastance (Ea=0.9XSBP/SV, SV=stroke volume). Sys-
temic vascular resistance index (SVRI)= mean arterial pressure/cardiac index.
Total arterial compliance (Ca)=SV/pulse pressure.
